Kendale Ritchey, MD
Podiatrist · Knoxville, TNNPI 1043296593
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,806 of the $2,269 with a category attached, or 79.6%. 16 manufacturers reported payments, led by Smith+Nephew at 48.0% of the total. Reporting peaked in 2019 at $718 and has fallen 86.0% since, to $100 in 2025.
Across 71 payments — averaging $31.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- Alpha Orthopedic Systems$478
- Organogenesis Inc.$135
- Stryker$111
- AstraZeneca$102
- Amgen$80
- plus $274 from 10 others
What the payments were for
- Food & beverage$1,80680%
- Education$46320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 47 | $1,089 |
| Alpha Orthopedic Systems | 2 | $478 |
| Organogenesis Inc. | 1 | $135 |
| Stryker | 2 | $111 |
| AstraZeneca | 1 | $102 |
| Amgen | 4 | $80 |
| Paratek Pharmaceuticals, Inc. | 4 | $63 |
| Arthrosurface Incorporated | 1 | $44 |
| Paragon 28, Inc. | 2 | $29 |
| Medtronic | 1 | $27 |
| Nevro Corp. | 1 | $25 |
| Alfasigma USA, Inc. | 1 | $21 |
| Abbott | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| GRT US Holding, Inc. | 1 | $16 |
| Averitas Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Affinity$135
- Grafix$133
- GRAFIX PL$133
- Stravix$133
- STRAVIX PL$133
How this compares
$2,269 in reported general payments places this provider in the 65th percentile of 105 podiatrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 68 | $1,116 |
| Colchicine | 12 | $622 |
| Mupirocin | 73 | $539 |
| Ondansetron OdtOndansetron | 18 | $255 |
| Ketoconazole | 14 | $254 |
| Cephalexin | 17 | $166 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $131 |
| Prednisone | 12 | $114 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $82 |
| Meloxicam | 18 | $79 |
| Doxycycline Hyclate | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Knoxville
- Abshan MalikKnoxville$13K
- Kelly BumpusKnoxville$8K
- David SandbergKnoxville$5K
- Timothy GardnerKnoxville$4K
- Heather SandbergKnoxville$3K
- Robert HancockKnoxville$1K
- Phillip HaslerKnoxville$1K
- Ivan CooperKnoxville$829
- James GilleyKnoxville$518
- Jeffrey LovelandSparta$809K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.